SOON logo

Sonova Holding Stock Price

Symbol: SWX:SOONMarket Cap: CHF 13.1bCategory: Healthcare

SOON Share Price Performance

CHF 220.60
-60.40 (-21.49%)
33.8% undervalued intrinsic discount
CHF 333.46
Fair Value
CHF 220.60
-60.40 (-21.49%)
33.8% undervalued intrinsic discount
CHF 333.46
Fair Value
Price CHF 220.60
AnalystHighTarget CHF 333.46
AnalystConsensusTarget CHF 260.47
AnalystLowTarget CHF 189.00

SOON Community Narratives

AN
AnalystHighTarget
AnalystHighTarget·Updated
Fair Value CHF 333.46 33.8% undervalued intrinsic discount

Global Aging And AI Tech Will Shape Hearing Care

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget·Updated
Fair Value CHF 260.47 15.3% undervalued intrinsic discount

Launch Of Infinio And Sphere Hearing Aids Will Drive Future Performance

0users have liked this narrative
0users have commented on this narrative
23users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget·Updated
Fair Value CHF 189.00 16.7% overvalued intrinsic discount

Low-Cost Rivals And Digital Shifts Will Erode Premium Pricing

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent SOON News & Updates

No updates

Sonova Holding AG Key Details

CHF 3.9b

Revenue

CHF 1.1b

Cost of Revenue

CHF 2.8b

Gross Profit

CHF 2.3b

Other Expenses

CHF 540.5m

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Nov 14, 2025
Earnings per share (EPS)
9.07
Gross Margin
72.43%
Net Profit Margin
13.98%
Debt/Equity Ratio
56.3%

Sonova Holding AG Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About SOON

Founded
1947
Employees
18351
CEO
Arnd Kaldowski
WebsiteView website
www.sonova.com

Sonova Holding AG manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segment engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing implants and related products under the Advanced Bionics brand. The company sells its products directly to end consumers through its own store network; wholesales to independent audiologists, third party retail chains, and multinational and government customers; and provides hearing care services through a network of stores and clinics. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.

Swiss Market Performance

  • 7 Days: -1.0%
  • 3 Months: -0.9%
  • 1 Year: 3.5%
  • Year to Date: 2.2%
In the last week, the market has been flat, with a notable exception in the Consumer Discretionary sector dropping 4.1%. As for the longer term, the market has risen 3.5% in the past 12 months. Looking forward, earnings are forecast to grow by 11% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading